ASX:API

AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED

James Gerrish

Yesterday’s momentum to the downside certainly continued through to today’s session as the local market opened strongly lower despite the UK & US markets both trading higher overnight. The ASX200 traded to a 2-week low early in the afternoon before staging a decent recovery over the last few hours including... Show More

Bell Potter

After a quiet year for global takeover activity in the pharmaceutical sector in 2017, Trump's tax cuts have fired up the appetite for acquisitions in the sector. US firms in particular have been active in snapping up undervalued Australian biotech assets. Show More

Mathan Somasundaram

Local market fell on the open and then traded sideways with weak global sentiment. The commodities remain strong on the back of China optimism…Shanghai index delivered another new high since 2015. Iron Ore continues to baffle analyst by moving higher while the Texas natural disaster playing into Oil optimism. Jackson... Show More

NAOS Asset Management

“The smaller players saw NBN as an opportunity because they didn’t have the ability to build the infrastructure. But when the commercial model was announced they realised that the commercial model didn’t work for them and the usage-based charging is contrary to the market dynamics we see in mobile and... Show More